Is a complete HRTX research report available?

No complete published report is available for Heron Therapeutics, Inc. (HRTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · USD

$0.46

-0.00 (-0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HRTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	86.3M
Revenue (ttm)	150.7M
Net income (ttm)	-30.9M
EPS (ttm)	-$0.18
Shares out	189.3M
Volume	1,159,345
Beta	1.65
Price target	$2.00	+338.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 150.7M
Net income (ttm): -30.9M
EPS (ttm): -$0.18
Market cap: 86.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All HRTX indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000818033
Company name	Heron Therapeutics, Inc.
Country	United States
Country code	US
Cusip	427746102
Employees	128
Employees Change	6%
Employees Change Percent	4.92
Enterprise value	$183.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1987-08-26
Isin	US4277461020
Last refreshed	2026-07-25
Market cap	$86.3M
Market cap category	Micro-Cap
Price	$0.46
Price currency	USD
Rev Per Employee	1,177,437.5x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	HRTX
Website	https://www.herontx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.86%
EV Sales Forward	1.4x
EV/Sales	1.22x
FCF yield	-24.18%
P/B ratio	10.63x
P/S ratio	0.57x
PS Forward	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.94%
EBITDA Margin	-5.42%
Gross margin	62.8%
Gross Profit	$94.6M
Gross Profit Growth	-0.89%
Gross Profit Growth Q	-23%
Net Income	$-30.9M
Net Income Growth Years	0%
Pretax Margin	-20.53%
Profit Margin	-20.53%
Profit Per Employee	$-241,727
ROA	-2.71
Roa5y	-21.48
ROCE	-6.72
ROIC	-4.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-30.22%
Cagr15y	-15.38%
Cagr1y	-76.77%
Cagr20y	-23.72%
Cagr3y	-30.87%
Cagr5y	-48.75%
EPS Growth Years	0
Revenue Growth	1.48x
Revenue Growth Q	-10.78x
Revenue Growth Years	4x
Revenue Growth3 Y	9.81x
Revenue Growth5 Y	12.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$246.2M
Cash	$44.8M
Current Assets	$229M
Current Liabilities	$90.5M
Debt	$141.6M
Debt Equity	$15.5
Equity	$9.1M
Interest Coverage	-0.88
Liabilities	$237.1M
Long Term Assets	$17.2M
Long Term Liabilities	$146.6M
Net Cash	$-96.9M
Net Cash By Market Cap	$-112
Net Debt Equity	$10.6
Tangible Book Value	$8.1M
Tangible Book Value Per Share	$0.04
WACC	9.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.53
Inventory Turnover	0.75
Net Working Capital	$93.7M
Quick ratio	1.42
Working Capital	$138.5M
Working Capital Turnover	$1.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.85%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.26%
1Y total return	-76.74%
200-day SMA	1.01
3Y total return	-66.97%
50-day SMA	0.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.46%
All Time High	1,290
All Time High Change	-99.96%
All Time High Date	1992-01-13
All Time Low	0.38
All Time Low Change	19.32%
All Time Low Date	2026-06-16
ATR	0.04
Beta	1.65
Beta1y	2.55
Beta2y	1.51
Ch YTD	-64.94
High	0.46
High52	1.97
High52 Date	2025-07-24
High52ch	-76.86%
Low	0.45
Low52	0.38
Low52 Date	2026-06-16
Low52ch	19.32%
Ma50ch	-16.76%
Premarket Change Percent	0.2
Premarket Price	$0.46
Premarket Volume	3,930
Price vs 200-day SMA	-54.83%
RSI	44.52
RSI Monthly	35.84
RSI Weekly	32.37
Sharpe ratio	-1.32x
Sortino ratio	-1.5
Total Return	-14.85%
Tr YTD	-64.94
Tr15y	-91.83%
Tr1m	8.89%
Tr1w	-3.17%
Tr3m	-54.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	42,240,000x
Earnings Revenue Estimate Growth	13.55x
Operating Income	$-10.5M
Operating margin	-6.94
Price target	$2
Price Target Change	$339

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	135,436,139%
Float Percent	71.55%
Net Borrowing	-12,755,000
Shares Insiders	0.92%
Shares Institutions	54.62%
Shares Out	189,279,369
Shares Qo Q	0.86%
Shares Yo Y	14.85%
Short Float	29.9%
Short Ratio	7.97
Short Shares	21.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-31.7M
Average Volume	2,889,720.3x
Bv Per Share	0.04
CAPEX	$-599,000
Ch10y	-97.26
Ch15y	-91.83
Ch1m	8.89
Ch1w	-3.17
Ch1y	-76.74
Ch20y	-99.55
Ch3m	-54.41
Ch3y	-66.97
Ch5y	-96.46
Ch6m	-67.9
Change	-0.7%
Change From Open	0.62
Close	0.46
Days Gap	-1.31
Depreciation Amortization	2,292,000
Dollar Volume	528,429.5
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-10.5M
EBITDA	$-8.2M
EPS	$-0.18
F Score	3
FCF	$-20.9M
FCF EV Yield	-11.39x
FCF Per Share	$-0.11
Financing CF	14,312,000
Fiscal Year End	December
Founded	1,983
Investing CF	12,797,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2014-01-13
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	0.94
Ma150ch	-51.51%
Ma20	0.44
Ma20ch	2.7%
Net CF	6,848,000
Next Earnings Date	2026-08-07
Open	0.45
Optionable	Yes
Position In Range	40.85
Post Close	0.46
Postmarket Change Percent	0.1
Postmarket Price	$0.46
Ppne	12,025,000
Pre Close	0.46
Price Date	2026-07-24
Ptbv Ratio	10.67
Relative Volume	0.4x
Revenue	150,712,000x
SBC By Revenue	7.17x
Share Based Comp	10,804,000
Tr20y	-99.55%
Tr6m	-67.9%
Us State	North Carolina
Volume	1,159,345
Z Score	-9.29

Heron Therapeutics, Inc. (HRTX)

Coverage state: Market snapshot only — no published research

Generate the first HRTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HRTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HRTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HRTX

Frequently asked questions